Topic
pharmaceutical
Logistics FedEx Launches Life Sciences Division to Integrate Healthcare Logistics Capabilities
FedEx Corp. announced the launch of FedEx Life Sciences, a dedicated division integrating its healthcare logistics services under one roof. The unit targets the $80 billion healthcare transportation market, leveraging cold-chain infrastructure, direct pharma flights, and AI-powered monitoring. The move underscores a broader industry shift among major parcel carriers toward high-margin premium segments.
TNAU patents high-yield eco-friendly cadambine extraction method from Kadamba tree
Tamil Nadu Agricultural University (TNAU) has secured a patent for a novel method to isolate and quantify cadambine from the Kadamba tree. The process delivers a 93-94% recovery yield while significantly reducing solvent consumption, waste generation, and processing time.
Trade Indian envoy pitches greater pharma exports, Chinese investment to deepen ties
India's envoy to China, Doraiswami, called for increased pharmaceutical exports to China and welcomed Chinese investment, speaking at Tsinghua University's World Peace Forum. He noted recent Indian policy changes to facilitate Chinese investment and normalisation of bilateral ties.
Manufacturing Wegovy Weight Loss Pill Now Available Privately in UK Pharmacies, Offers Needle-Free Alternative
The once-a-day Wegovy weight loss pill, containing semaglutide, is now available to buy privately from High Street and online pharmacies in the UK. It offers an alternative to the injection, with similar effectiveness, but requires strict dosing guidelines including fasting before each dose. Key differences and eligibility criteria are outlined.
Manufacturing Semaglutide therapy market faces Rs 100 crore excess stock after initial rush
The Indian semaglutide therapy market is facing an excess stock of approximately Rs 100 crore, with stockists holding 50-60 days of inventory after a sharp slowdown in May sales. The market had surged following patent expiry in March but growth slowed drastically, leading to a halt in fresh procurement from pharmaceutical companies.
Technology Novo Nordisk Reveals Clinical Trials Data Breached in Cyberattack, Patient IDs Exposed
Novo Nordisk, the maker of Ozempic and Wegovy, confirmed a cyberattack that breached pseudonymized clinical trial data, including patient IDs, biomarkers, and lifestyle factors. The company stated no personally identifiable information (PII) was exposed and core operations remain unaffected. Third-party cybersecurity experts are investigating.